description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
AGATGCCTTTTGATGCCAACAAACTGTATTGCAGTGAAGTGCTGGCCATATTGCTCCAGGACAATGATGAAAACAGGGAATTGCTTGGGGAGCTGGATGGAATCGATGTGCTTCTTCAGCAGTTATCCGTGTTTAAAAGACACAATCCCAGCACGGCTGAGGAGCAGGAGATGATGGAGAATCTGTTTGATTCCCTCTGCTCCTGTCTAATGCTTAGTTCCAATCGTGAGCGCTTCCTGAAGGGCGAGGGTCTTCAGCTGATGAATCTCATGCTCAGGGAAAAGAAGATCTCCCGGAGCAGTGCCCTGAAAGTGCTGGACCATGCCATGATTGGCCCCGAAGGCACAGACAACTGCCATAAGTTTGTTGACATTCTTGGCTTACGAACCATCTTTCCCCTCT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... CTNNBL1(56259)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Yingwei Li et al.
Experimental cell research, 357(1), 124-134 (2017-05-16)
Ovarian cancer is the most lethal gynecologic malignancy and the molecular pathogenesis of high-grade serous ovarian carcinoma has not been completely characterized. Numerous studies have shown that altered splicing patterns and splicing factors were found to contribute to tumor development
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU115271-50UG | 04061828389964 |
| EHU115271-20UG | 04061828615278 |